Ming Dong Zhou
Chief Executive Officer at Zensun (Shanghai) Sci & Tech Co., Ltd.
Profile
Ming Dong Zhou is the Chairman & General Manager of Zensun (Shanghai) Sci & Tech Co., Ltd., which he founded in 2000.
He is also the Co-Chairman of Zensun USA, Inc. where he currently works.
Previously, he worked as a Principal at The Victor Chang Cardiac Research Institute.
Dr. Zhou holds a doctorate degree from The State University of New York, which he received in 1992, and an undergraduate degree from Fudan University, which he received in 1982.
Ming Dong Zhou active positions
| Companies | Position | Start |
|---|---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
 Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Chief Executive Officer | 2003-05-31 |
Zensun USA, Inc.
 Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | Chairman | - |
Former positions of Ming Dong Zhou
| Companies | Position | End |
|---|---|---|
The Victor Chang Cardiac Research Institute
 The Victor Chang Cardiac Research Institute Miscellaneous Commercial ServicesCommercial Services The Victor Chang Cardiac Research Institute is a research center dedicated to finding cures for heart disease through world-class and cutting-edge medical research. The institute is located in Western Australia and is the first dedicated center of heart research in the region. The scientists at the institute are urgently working to discover better ways of understanding, diagnosing, treating, and preventing the onset of heart disease. The CEO of the Australian company is Mark Rodrick Granger Johnson. | Corporate Officer/Principal | - |
Training of Ming Dong Zhou
| Fudan University | Undergraduate Degree |
| The State University of New York | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Health Technology |
The Victor Chang Cardiac Research Institute
The Victor Chang Cardiac Research Institute Miscellaneous Commercial ServicesCommercial Services The Victor Chang Cardiac Research Institute is a research center dedicated to finding cures for heart disease through world-class and cutting-edge medical research. The institute is located in Western Australia and is the first dedicated center of heart research in the region. The scientists at the institute are urgently working to discover better ways of understanding, diagnosing, treating, and preventing the onset of heart disease. The CEO of the Australian company is Mark Rodrick Granger Johnson. | Commercial Services |
Zensun USA, Inc.
Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | Health Technology |
- Stock Market
- Insiders
- Ming Dong Zhou
